Lead sponsor
Tisento Therapeutics
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
0
Ongoing
12
Total enrollment
5
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Trials by status
Terminated
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Study of the Effects of CY6463 in Participants With Alzheimer's Disease With Vascular PathologyAlzheimer's diseasePh 2Terminated12